Advances in asthma, asthma-COPD overlap, and related biologics in 2018.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31476323.
- Also identified by DOI 10.1016/j.jaci.2019.08.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Over the past year, numerous important advances in our understanding of multiple aspects of asthma, ranging from disease pathogenesis to epidemiology to therapeutics, have been reported. This review is a compilation of highlights from articles published largely in the Journal of Allergy and Clinical Immunology and supplemented by articles published elsewhere that have substantially advanced the fields of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap and biologic therapies for these disorders. The intention of this article is not to provide a comprehensive review but rather to focus on several areas that have developed quickly and/or received extensive attention from our readers.
Medical subject headings
- Asthma
- Pulmonary Disease, Chronic Obstructive